Enterprise Therapeutics Funding: $41M Raised, Series B
Enterprise Therapeutics is based in Brighton, United Kingdom. It has raised $41M in total funding. Latest round: Series B.
Enterprise Therapeutics funding overview
Enterprise Therapeutics is based in Brighton, United Kingdom. Enterprise Therapeutics has raised $41M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2018. The round record for Enterprise Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Versant Ventures, Novartis Venture Fund. 2 distinct backers are named across the disclosed rounds.
Enterprise Therapeutics at a glance
Total raised
$41M
Latest round
Series B
Latest round date
January 2018
Headquarters
Brighton, United Kingdom
Notable investors
Versant Ventures, Novartis Venture Fund
Frequently asked about Enterprise Therapeutics funding
How much has Enterprise Therapeutics raised?
Enterprise Therapeutics has raised $41M in total disclosed funding across the rounds on record.
Who has invested in Enterprise Therapeutics?
Versant Ventures, Novartis Venture Fund are named among the investors backing Enterprise Therapeutics.
What was the latest Enterprise Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2018.
Where is Enterprise Therapeutics based?
Enterprise Therapeutics is based in Brighton, United Kingdom.
When did Enterprise Therapeutics last raise?
The last disclosed Enterprise Therapeutics round closed in January 2018 at Series B.
We update the Enterprise Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Brighton and their backers are listed below.
